{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T05:55:13Z","timestamp":1774331713760,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12882-017-0538-1","type":"journal-article","created":{"date-parts":[[2017,4,18]],"date-time":"2017-04-18T08:13:52Z","timestamp":1492503232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Strategies and cost-effectiveness evaluation of persistent albuminuria screening among high-risk population of chronic kidney disease"],"prefix":"10.1186","volume":"18","author":[{"given":"Huaiyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luxia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,4,18]]},"reference":[{"issue":"9","key":"538_CR1","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrneph.2013.146","volume":"9","author":"ZH Liu","year":"2013","unstructured":"Liu ZH. Nephrology in china. Nat Rev Nephrol. 2013;9(9):523\u20138.","journal-title":"Nat Rev Nephrol"},{"key":"538_CR2","unstructured":"Garabed Eknoyan, Norbert Lameire, Kai-Uwe Eckardt, Bertram L Kasiske, Wheeler DC. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter., Suppl. 2013;3:1-150."},{"issue":"8","key":"538_CR3","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","volume":"110","author":"D Zeeuw de","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy. Circulation. 2004;110(8):921\u20137.","journal-title":"Circulation"},{"issue":"9176","key":"538_CR4","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/S0140-6736(98)10363-X","volume":"354","author":"P Ruggenenti","year":"1999","unstructured":"Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354(9176):359\u201364.","journal-title":"Lancet"},{"issue":"14","key":"538_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta18140","volume":"18","author":"AJ Farmer","year":"2014","unstructured":"Farmer AJ, Stevens R, Hirst J, Lung T, Oke J, Clarke P, Glasziou P, Neil A, Dunger D, M Colhoun H, et al. Optimal strategies for identifying kidney disease in diabetes: properties of screening tests, progression of renal dysfunction and impact of treatment - systematic review and modelling of progression and cost-effectiveness. Health Technol Assess. 2014;18(14):1\u2013128.","journal-title":"Health Technol Assess"},{"issue":"5","key":"538_CR6","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","volume":"60","author":"National Kidney Foundation","year":"2012","unstructured":"National Kidney Foundation. KDOQI clinical practice guideline for diabetes and CKD: 2012 update. Am J Kidney Dis. 2012;60(5):850\u201386.","journal-title":"Am J Kidney Dis"},{"key":"538_CR7","doi-asserted-by":"publisher","unstructured":"Johnson DW, Atai E, Chan M, Phoon RK, Scott C, Toussaint ND, Turner GL, Usherwood T, Wiggins KJ. KHA-CARI Guideline: Early chronic kidney disease: Detection, prevention and management. Nephrology. 2013;18(5):340\u201350.","DOI":"10.1111\/nep.12052"},{"issue":"5","key":"538_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/ki.2013.220","volume":"84","author":"LS Hooi","year":"2013","unstructured":"Hooi LS, Ong LM, Ahmad G, Bavanandan S, Ahmad NA, Naidu BM, Mohamud WN, Yusoff MF. A population-based study measuring the prevalence of chronic kidney disease among adults in West Malaysia. Kidney Int. 2013;84(5):1034\u201340.","journal-title":"Kidney Int"},{"issue":"23","key":"538_CR9","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1001\/jama.290.23.3101","volume":"290","author":"L Boulware","year":"2003","unstructured":"Boulware L, Jaar BG, Tarver-Carr ME, Brancati FL, Powe NR. Screening for proteinuria in us adults: a cost-effectiveness analysis. JAMA. 2003;290(23):3101\u201314.","journal-title":"JAMA"},{"issue":"2","key":"538_CR10","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10157-011-0567-1","volume":"16","author":"M Kondo","year":"2012","unstructured":"Kondo M, Yamagata K, Hoshi SL, Saito C, Asahi K, Moriyama T, Tsuruya K, Yoshida H, Iseki K, Watanabe T. Cost-effectiveness of chronic kidney disease mass screening test in Japan. Clin Exp Nephrol. 2012;16(2):279\u201391.","journal-title":"Clin Exp Nephrol"},{"issue":"9818","key":"538_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815\u201322.","journal-title":"Lancet"},{"issue":"17","key":"538_CR12","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","volume":"298","author":"J Coresh","year":"2007","unstructured":"Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the united states. JAMA. 2007;298(17):2038\u201347.","journal-title":"JAMA"},{"issue":"3","key":"538_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.ajkd.2007.11.009","volume":"51","author":"L Zhang","year":"2008","unstructured":"Zhang L, Zhang P, Wang F, Zuo L, Zhou Y, Shi Y, Li G, Jiao S, Liu Z, Liang W, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373\u201384.","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"538_CR14","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1053\/j.ajkd.2013.06.016","volume":"62","author":"CN Naresh","year":"2013","unstructured":"Naresh CN, Hayen A, Weening A, Craig JC, Chadban SJ. Day-to-day variability in spot urine albumin-creatinine ratio. Am J Kidney Dis. 2013;62(6):1095\u2013101.","journal-title":"Am J Kidney Dis"},{"issue":"12","key":"538_CR15","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1038\/ki.2011.368","volume":"80","author":"WG Couser","year":"2011","unstructured":"Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int. 2011;80(12):1258\u201370.","journal-title":"Kidney Int"},{"issue":"5","key":"538_CR16","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1053\/j.ajkd.2013.12.012","volume":"63","author":"P Komenda","year":"2014","unstructured":"Komenda P, Ferguson TW, Macdonald K, Rigatto C, Koolage C, Sood MM, Tangri N. Cost-effectiveness of primary screening for CKD: a systematic review. Am J Kidney Dis. 2014;63(5):789\u201397.","journal-title":"Am J Kidney Dis"},{"key":"538_CR17","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1046\/j.1523-1755.2002.00356.x","volume":"61","author":"AX Garg","year":"2002","unstructured":"Garg AX, Kiberd BA, Clark WF, Haynes RB, Clase CM. Albuminuria and renal insufficiency prevalence guides population screening: results from the NHANES III. Kidney Int. 2002;61:2165\u201375.","journal-title":"Kidney Int"},{"key":"538_CR18","unstructured":"China Health and Family Planning Statistical Yearbook 2013 [ http:\/\/www.nhfpc.gov.cn\/ewebeditor\/uploadfile\/2014\/04\/20140430131845405.pdf ]."},{"issue":"10","key":"538_CR19","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1681\/ASN.2006040368","volume":"17","author":"YC Ma","year":"2006","unstructured":"Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, Li Y, Xu JS, Huang SM, Wang LN, Huang W, et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol. 2006;17(10):2937\u201344.","journal-title":"J Am Soc Nephrol"},{"key":"538_CR20","doi-asserted-by":"crossref","unstructured":"Wu Jingjing YL: The Quality Of Life And Work Ability In Patients With Chronic Kidney Disease In Urban China. In: ISPOR 19th Annual International Meeting. vol. 17: Value in Health; 2014: A142.","DOI":"10.1016\/j.jval.2014.03.825"},{"key":"538_CR21","unstructured":"Beijing Municipal Commission of Development and Reform [ http:\/\/www.bjpc.gov.cn\/ ]."},{"issue":"9200","key":"538_CR22","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","volume":"355","author":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators","year":"2000","unstructured":"Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000;355(9200):253\u20139.","journal-title":"Lancet"},{"key":"538_CR23","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","volume":"65","author":"D Zeeuw de","year":"2004","unstructured":"de Zeeuw D, Remuzzi G, Parving HH, Keane WF, Zhang Z, Shahinfar S, Snapinn S, Cooper ME, Mitch WE, Brenner BM. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL. Kidney Int. 2004;65:2309\u201320.","journal-title":"Kidney Int"},{"issue":"2","key":"538_CR24","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ahj.2011.05.004","volume":"162","author":"TI Chang","year":"2011","unstructured":"Chang TI, Shilane D, Brunelli SM, Cheung AK, Chertow GM, Winkelmayer WC. Angiotensin-converting enzyme inhibitors and cardiovascular outcomes in patients on maintenance hemodialysis. Am Heart J. 2011;162(2):324\u201330.","journal-title":"Am Heart J"},{"issue":"9","key":"538_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.7326\/0003-4819-131-9-199911020-00005","volume":"131","author":"L Golan","year":"1999","unstructured":"Golan L, Birkmeyer JD, Welch HG. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors. Ann Intern Med. 1999;131(9):7.","journal-title":"Ann Intern Med"},{"issue":"5","key":"538_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/00005650-199305000-00003","volume":"31","author":"MSC Murray Krahn","year":"1993","unstructured":"Murray Krahn MSC, Gafni A. Discounting in the economic evaluation of health care interventions. Med Care. 1993;31(5):403\u201318.","journal-title":"Med Care"},{"issue":"3","key":"538_CR27","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.ajkd.2009.11.017","volume":"55","author":"TJ Hoerger","year":"2010","unstructured":"Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, et al. A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening. Am J Kidney Dis. 2010;55(3):463\u201373.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"538_CR28","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1681\/ASN.2010111217","volume":"22","author":"WF Clark","year":"2011","unstructured":"Clark WF, Macnab JJ, Sontrop JM, Jain AK, Moist L, Salvadori M, Suri R, Garg AX. Dipstick proteinuria as a screening strategy to identify rapid renal decline. J Am Soc Nephrol. 2011;22(9):1729\u201336.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"538_CR29","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1681\/ASN.2008030292","volume":"20","author":"EC Witte","year":"2009","unstructured":"Witte EC, Lambers Heerspink HJ, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort R. First morning voids are more reliable than spot urine samples to assess microalbuminuria. J Am Soc Nephrol. 2009;20(2):436\u201343.","journal-title":"J Am Soc Nephrol"},{"issue":"9731","key":"538_CR30","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"Chronic Kidney Disease Prognosis Consortium","year":"2010","unstructured":"Chronic Kidney Disease Prognosis Consortium. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010;375(9731):2073\u201381.","journal-title":"Lancet"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-017-0538-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T01:37:16Z","timestamp":1569029836000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-017-0538-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,18]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["538"],"URL":"https:\/\/doi.org\/10.1186\/s12882-017-0538-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,18]]},"article-number":"135"}}